Septerna (SEPN) Operating Expenses (2023 - 2026)
Septerna's (SEPN) quarterly Operating Expenses came in at $6.2 million in Q1 2026, up 25.35% year-on-year from $4.9 million in Q1 2025, and down 93.73% quarter-over-quarter from $98.2 million in Q4 2025.
Septerna (SEPN) Operating Expenses (2023 - 2026) Analysis & Trends
Septerna's Operating Expenses history runs 4 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 25.35% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was $152.4 million, a 55.91% increase from a year earlier, with the FY2025 full-year figure at $114.2 million, up 39.5% from the prior year.
- Operating Expenses eased to $6.2 million in Q1 2026 per SEPN's latest filing, from $98.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $98.2 million in Q4 2025 and bottomed at -$34.2 million in Q4 2023.
- The 4-year median for Operating Expenses is $15.8 million (2024), against an average of $22.2 million.
- Biggest YoY gain for Operating Expenses was 317.54% in 2025; the steepest drop was 68.93% in 2025.
- Year by year, Operating Expenses stood at -$34.2 million in 2023, then surged by 304.29% to $69.9 million in 2024, then surged by 40.62% to $98.2 million in 2025, then tumbled by 93.73% to $6.2 million in 2026.
- Per Business Quant, the three latest SEPN Operating Expenses figures stand at $6.2 million (Q1 2026), $98.2 million (Q4 2025), and $18.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Septerna | 1.48 Bn | 1.48 Bn | - | 6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.16 Mn |
| Dec 31, 2025 | 98.25 Mn |
| Sep 30, 2025 | 18.88 Mn |
| Jun 30, 2025 | 29.10 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 69.87 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 18.44 Mn |
| Mar 31, 2024 | 15.81 Mn |
| Dec 31, 2023 | -34.20 Mn |
| Sep 30, 2023 | 12.07 Mn |